Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: A review
The presence of a mucus layer that covers the surface of a variety of organs has been
capitalized to develop mucoadhesive dosage forms that remain in the administration site for …
capitalized to develop mucoadhesive dosage forms that remain in the administration site for …
Allergic rhinitis
AN Greiner, PW Hellings, G Rotiroti, GK Scadding - The Lancet, 2011 - thelancet.com
Allergic rhinitis is a very common disorder that affects people of all ages, peaking in the
teenage years. It is frequently ignored, underdiagnosed, misdiagnosed, and mistreated …
teenage years. It is frequently ignored, underdiagnosed, misdiagnosed, and mistreated …
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k guideline of the German society for allergology and clinical immunology (DGAKI …
O Pfaar, C Bachert, A Bufe, R Buhl, C Ebner… - Allergo journal …, 2014 - Springer
The present guideline (S2k) on allergen-specific immunotherapy (AIT) was established by
the German, Austrian and Swiss professional associations for allergy in consensus with the …
the German, Austrian and Swiss professional associations for allergy in consensus with the …
[HTML][HTML] Sublingual immunotherapy: World Allergy Organization position paper 2013 update
GW Canonica, L Cox, R Pawankar… - World Allergy …, 2014 - Elsevier
We have prepared this document,“Sublingual Immunotherapy: World Allergy Organization
Position Paper 2013 Update”, according to the evidence-based criteria, revising and …
Position Paper 2013 Update”, according to the evidence-based criteria, revising and …
Allergen immunotherapy: a practice parameter third update
L Cox, H Nelson, R Lockey, C Calabria… - Journal of Allergy and …, 2011 - jacionline.org
This document builds on the previous Joint Task Force document ''Allergen immunotherapy:
a practice parameter second update''published in the Journal of Allergy and Clinical …
a practice parameter second update''published in the Journal of Allergy and Clinical …
Update on allergy immunotherapy: American academy of allergy, asthma & immunology/European academy of allergy and clinical immunology/PRACTALL …
AW Burks, MA Calderon, T Casale, L Cox… - Journal of Allergy and …, 2013 - Elsevier
Allergy immunotherapy (AIT) is an effective treatment for allergic asthma and rhinitis, as well
as venom-induced anaphylaxis. In addition to reducing symptoms, AIT can change the …
as venom-induced anaphylaxis. In addition to reducing symptoms, AIT can change the …
Practical guide to skin prick tests in allergy to aeroallergens
J Bousquet, L Heinzerling, C Bachert… - Allergy, 2012 - Wiley Online Library
To cite this article: Bousquet J, Heinzerling L, Bachert C, Papadopoulos NG, Bousquet PJ,
Burney PG, Canonica GW, Carlsen KH, Cox L, Haahtela T, Lodrup Carlsen KC, Price D …
Burney PG, Canonica GW, Carlsen KH, Cox L, Haahtela T, Lodrup Carlsen KC, Price D …
Бронхиальная астма у детей
ИИ Балаболкин, ВА Булгакова - 2015 - elibrary.ru
Бронхиальная астма—хроническое воспалительное заболевание дыхательных путей,
сопровождаемое гиперреактивностью бронхов и клинически проявляемое их …
сопровождаемое гиперреактивностью бронхов и клинически проявляемое их …
SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial
BACKGROUND: The main aim of specific immunotherapy is sustained effect due to changes
in the immune system that can be demonstrated only in long-term trials. OBJECTIVE: To …
in the immune system that can be demonstrated only in long-term trials. OBJECTIVE: To …
A WAO-ARIA-GA²LEN consensus document on molecular-based allergy diagnostics
GW Canonica, IJ Ansotegui, R Pawankar… - World Allergy …, 2013 - Springer
Molecular-based allergy (MA) diagnostics is an approach used to map the allergen
sensitization of a patient at a molecular level, using purified natural or recombinant …
sensitization of a patient at a molecular level, using purified natural or recombinant …